In addition, although the HEART-FID trial used criteria for iron deficiency that have consistently been used in previous trials of ferric carboxymaltose, debate about the criteria remains. 16 Of ...

When Fudi Wang set out to understand the biology of bio-metals such as selenium, zinc, iron, manganese, and copper, he never imagined his research would culminate in a deeper understanding of how ...

Iron induces chronic heart failure in half of heart attack survivors. ScienceDaily. Retrieved May 29, 2025 from www.sciencedaily.com / releases / 2022 / 11 / 221101151950.htm.

In iron-deficient patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, intravenous ferric carboxymaltose (FCM) is associated with a reduced risk of the ...

IV iron therapy significantly lowers the risk of hospitalization in heart failure patients with iron deficiency, improving outcomes and quality of life. About Careers Internship MedBlog Contact us ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according ...